PWMS News Search Results

Back to
   Back to PeopleWithMS NewsWire 

July 2, 2007 Off the Wire . . .



PeopleWithMS - NewsWire

Enrollment Begins For Study Of MBP8298 In SPMS

Enrollment has begun for a study testing the safety and effectiveness of the experimental drug MBP8298 (BioMS Medical Corp.) in 510 people with secondary-progressive multiple sclerosis. Up to 60 sites nationwide will be enrolling patients by September. This drug is administered intravenously (into the vein) every 6 months.

Trial enrollment info here

E-Mail the NewsWire - Handpainted and Customized Canes
 with any news items you discover 

©copyright 2003